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Abstract 
Background: Malaria is a major public health problem in the world in general and developing countries in particular, 
causing an estimated 1-2 million deaths per year, an annual incidence of 300-500 million clinical cases and more than 
2 billion people are at risk of infection from it. But it is also becoming more difficult to treat malaria due to the 
increasing drug resistance. Therefore, the need for alternative drugs is acute. 
Objective: This study aims at investigating the in vivo antiplasmodial activity of extracts of the roots and area parts 
from traditionally used medicinal plant, named Asparagus africanus  (Liliaceae). 
Methods: A rodent malaria parasite, Plasmodium berghei, which was maintained at the Ethiopian Health and 
Nutrition Research Institute (EHNRI) laboratory, was inoculated into Swiss albino mice. The mice were infected with 
1x107 parasites intraperitoneally. The extracts were administered by an intra gastric tube daily for four days starting 
from the day of parasite inoculation. The control groups received the same amount of solvent (vehicle) used to suspend 
each dose of the herbal drug. Chloroquine was used as a standard drug, and was administered through the same route. 
Results: Extracts from the roots and aerial parts of A.africanus were observed to inhibit Plasomodium berghei 
parasitaemia in the Swiss albino mice by 46.1% and 40.7% respectively.  
Conclusion: The study could partly confirm the claim in Ethiopian traditional medicine that the plant has therapeutic 
values in human malaria.  There is, thus, the need to initiate further in-depth investigation by using different 
experimental models.  [Ethiop.J.Health Dev. 2006;20(2):112-118] 
 
Introduction 
Malaria is an infectious disease caused by the parasite 
Plasmodia. Four identified species of this parasite exist, 
which cause different types of human malaria, namely; 
Plasmodium vivax, Plasmodium falciparum, Plasmodium 
ovale & Plasmodium malariae, all of which are 
transmitted by the female anopheles mosquito (1). 
Although all the four species of malaria parasites can 
infect humans and cause illness, only the malaria type 
caused by Plasmodium falciparum is known to be 
potentially life threatening. Infection with P.falciparum 
is, therefore, a medical emergency. About 2% of persons 
infected with falciparum malaria die, usually because of 
delayed treatment (2). The present global situation 
indicates a recent resurgence in the severity of the disease 
and that malaria could still be described as one of the 
most important communicable diseases, with an annual 
incidence of 300-500 million clinically manifest cases 
and a death toll of 1-2 million people (3-6). 
 
In earlier times the common oral treatment for 
uncomplicated falciparum malaria was limited to 
chloroquine, in chloroquine sensitive cases of malaria, 
and to quinine sulfate or mefloquine, tetracycline or 
doxcycline, sulfadoxine/pyrimethamine (SP) in 
chloroquine resistant cases (7-8). Chloroquine - a 
prominent antimalarial drug - has been the first line drug 
used for the treatment of uncomplicated malaria, over the 
last forty years in Ethiopia. The first report on 
chloroquine failure to clear asexual P. falciparum 
parasites from the blood of patients infected in various 
parts of Ethiopia appeared in 1986. Since then the 
resistance has been exponentially increasing in Ethiopia 
as well its neighboring countries (9-13).  
 
One of the areas for the search for new antimalarials is 
the traditionally claimed antimalarial plant from the 
African flora (14,15). Medicinal plants have been the 
focus of many anti-infective drugs and alternative 
sources of animalarial agents in various parts of the 
world since long ago (16). Studies have been conducted 
on traditionally claimed medicinal plants in Ethiopia and 
elsewhere for scientific validation (17-19). This is 
because they have been part of human life since time 
immemorial; and a number of plant products have been 
in extensive use in ethno medicine (20,21).  
 
One of the most impressive developments in the history 
of medicine is the emergence of the Peruvian (Cinchona) 
bark (Rubiaceae) coupled with its pharmacologically 
active substance, - the quinine. Quinine is a classic 
antimalarial drug found in the bark of a tree that is native 
to South America (6,22). Artemisinin derivatives taken 
from the leaves of the Chinese herbal drug Artemisa 
annua, for instance, are plant products, which have been 
in use as traditional medicine for centuries for the 
treatment of malaria. The standard antimalarials, 
chloroquine and mefloquine, were also derived by 
modifying the basic chemical structure of quinine 
(22,23). The development of plant-based drugs that are 
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used to treat this devastating disease, therefore, should be 
given utmost priority. 
 
A number of studies have been conducted on the in vitro 
evaluation of the anti-malarial activity of Ethiopian 
traditional medicinal plants. It has been reported that 
extracts from plants such as Hagenia abysinica, 
Berssama abysinica, Artemesia afra, Artemesia rehan 
and Ajuga remota (24), as well as Withania somenifer, 
and Vernonia amygdalina (25), have significant 
antimalarial activity against P.falciparum. An in vitro 
study previously conducted on extracts from the root of 
Asparagus africanus has shown a counter activity against 
four different malaria schizont strains (26). Two 
antiprotozoal compounds, a sapogenin (muzanzagenin) 
and lignan ((+) nyasol) were also isolated and were 
reported to be responsible for the antimalarial activity 
(26). Other in vitro studies on African medicinal plants 
have also indicated promising antiplasmodial activities 
(27, 28) though no remarkable in vivo studies have been 
reported so far to strengthen the preclinical study profile. 
Therefore, this study aims at investigating the in vivo 
antiplasmodial activity of extracts from a traditionally 
used medicinal plant, Asparagus africanus Lam. which is 
extracted from Liliaceae roots and aerial parts 
 
Methods 
Plant collection and sample preparation: The roots and 
aerial parts of Asparagus africanus, were collected from 
the vicinities of Shashamane and Awassa towns (about 
270 km south of Addis Ababa), where they are used as 
traditional treatment for malaria. The Voucher specimens 
(Herb No, AA-2163) were deposited at the Herbarium of 
the Department of Drug Research (DDR) at the Ethiopian 
Health and Nutrition Research Institute (EHNRI). The plant 
parts were garbled and dried in the processing room, and 
were then powdered and kept at room temperature in a 
well-closed and amber coloured bottle until extracted.  
 
The air-dried and powdered plant materials (100g) were 
extracted by maceration with 80% methanol for three 
consecutive days at room temperature. The extracts were 
then filtered and concentrated under vacuum in a rotary 
evaporator to yield 13%- 28% of gummy residue, as extract 
of plant parts. The extracts were kept in a tightly closed 
bottle in a refrigerator until used for anti-malarial testing.  
 
In vivo antimalarial tests: Tests were performed in a 4-
day suppressive standard test using the methods of 
David, Thurston and Peters (2,6). The plasmodium 
species, that is most widely employed in rodent malaria 
parasite-Plasmodium berghei (chloroquine sensitive 
strain), was used to infect Swiss albino mice for a four-
day suppressive test. The P. berghei was subsequently 
maintained in the laboratory by serial blood passage from 
mouse to mouse. For the study, a donor mouse with a 
rising parasitemia of 20% was sacrificed and its blood 
was collected in a slightly heparinized syringe from the 
auxiliary vessels. The blood was diluted with Trisodium 
Citrate (TC) medium so that each 0.2 ml contained 
approximately 107 infected red cells (2,6). Each animal 
received inoculums of about 10 million parasites per 
gram body weight, which is expected to produce a 
steadily rising infection in mice. 
 
Male Swiss albino mice belonging to strains maintained 
at the EHNRI animal sanctuary were used. The mice 
were allowed to acclimatize to the laboratory 
environment under a controlled temperature of 200 C and 
at optimum humidity for at least three days before being 
subjected to the experiments (2). All the experiments 
were carried out in a calm laboratory setting that has 
ambient illuminations and a temperature that is close to 
those in the animal sanctuary (2). The mice were divided 
into five groups of six each, and which were all infected 
with malaria parasites. Three of the groups were made to 
receive extract treatments, while the fourth group 
received the vehicle (negative control) and the fifth 
received chloroquine (the standard antimalarial drug).  
 
The infection of the recipient mice was initiated by 
needle passage of the above mentioned parasite 
preparation, from the donor to healthy test animals via an 
intraperitoneal route (2,6). Therefore, P. berghei infected 
red blood cells were intraperitoneally injected into the 
mice from the blood diluted with TC medium so that 
each 0.2 ml had approximately 10 6- 107 infected red cells 
(parasite per kg of body weight). Each mouse was 
infected with single inoculums of 0.2 ml blood.  
 
The 4-day procedures were started on Mondays while 
blood smears for parasitemia were collected on Fridays. 
The infected mice were weighed, randomly divided into 
treatment, vehicle and standard drug groups. The 
treatment group, sub divided into sub groups 1, 2 and 3, 
received extracts from the A. africanus root (200 mg/kg, 
400 mg/kg and 600 mg/kg). Group 4 received the vehicle 
(5 drops 10% Ethanol in double distilled water); while the 
fifth group received chloroquine 10 mg/kg, daily for 4 days, 
starting on the same day as that of the parasite inoculation. 
The same study was repeated on A. africanus aerial parts 
(200 mg/kg, 400 mg/kg and 600 mg/kg). 
 
The plant extracts were administered through intra gastric 
route using the stomach tube to ensure the safe ingestion of 
the extracts and the vehicle. The dose levels of the extracts 
were selected from a pilot study carried out in mice, and 
which is also based on information obtained from literature 
on traditional methods of usage of these plants (21). The 
extracts were dissolved to the indicated suitable dose 
levels in solution and suspension, the later requiring the 
addition of 5 drops of 10% ethanol in 10 ml double 
distilled water and the vehicle (5 drop 10% Ethanol and 
double distilled water). All were given daily for 4 
consecutive days starting 3 hours after infection, i.e. from 
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day 0 (D0) to day 3(D3), receiving a total of 4 intra gastric 
doses (6). 
Thin smears of blood films were obtained from the 
peripheral blood on the tail from each mouse on day four 
after infection (6,29). The smears were placed on 
microscopic slides, fixed with methanol and stained with 
Gemsa at pH 7.2, for parasitemia. The microscope had an 
Ehrlich’s eyepiece and a nose diaphragm showing about 
100 red blood cells per field. The number of parasitized 
erythrocytes in each of the 10-50 such fields were 
counted three times and the average was calculated to 
give the Parasitemia of each individual animal. 
Percentage of suppression was calculated by using the 
following formula (2,6,29). 
 
% Suppression = Parasitemia in negative control-Parasitemia in study group  
                                                   Parasitemia in negative control 
 
The body weights of the mice were measured to observe 
whether the test extracts of A. africanus roots and aerial 
parts prevented the weight loss that is commonly reduced 
with increasing parasitemia in infected mice. The weights 
were taken on D0 and D4. 
 
The Packed Cell Volume (PCV) was measured to predict 
the effectiveness of the test extracts using the modified 
Wintrobe’s Method (29). Blood from the tail of the 
animals was then drawn and duplicate and triplicate 
determinations were done by measuring the relative 
volume of the blood occupied by erythrocytes, using the 
relation: 
       
Packed Cell Volume = Volume of erythrocytes in a given volume of blood  
                                                        Total blood volume 
 
PCV is a measure of the proportion of red blood cells to 
plasma. This test was done from each mouse just before 
infection and on the 5th day of the infection. 
 
The daily measurement of rectal temperature was also 
undertaken to predict the effectiveness of the test 
extracts. It is theoretically accepted that the body 
temperature of mice decreased in a rapid manner with 
increasing parasitemia, contrary to the situation in human 
subjects. The test extracts are determined by observing 
the protective effect of the extracts against the rapid fall 
in temperature (30). The study as well as the control 
animals were checked for a reduction in body 
temperature, by using rectal thermometers conducted 
daily for six consecutive days starting from the day prior 
to parasite inoculation.  
 
Acute and sub acute toxicity tests were done for A. 
africanus roots and aerial parts. Four groups of mice, each 
group having 5 male & 5 female mice, for dose levels 
(1000 mg/kg, 2000 mg/kg and 3000 mg/kg), and one group 
for the highest dose (5000 mg/kg) were used for both A. 
africanus plant parts. The mice were acclimatized and 
fasted over night. The weight of each mouse was 
measured and calculated for all the dose levels. The 
extracts were given to the mice before they ate anything 
(empty stomachs). The test was repeated with lower 
doses (100 mg/kg, 200 mg/kg and 500 mg/kg) and finally 
with 1000 mg/kg intraperitoneally. Toxicity signs such as 
death, changes in physical appearance, behavioral 
change, and organ damage were observed for 72 hours. 
 
Data analysis: Data on parasitemia, body weight, packed 
cell volume and body temperature were analysed using 
Windows SPSS Version 8. The one-way ANOVA, the 
Student’s t-test and independent comparison tests were 
used to compare results among and within groups for 
difference between initial and final results. All data were 
analysed at a 95% confidence interval (α = 0.05).  
 
Results 
The results of the study indicated that in vivo, hydro 
alcoholic extracts of A. africanus displayed a very good 
activity against the P. berghei malaria parasite. The 
comparison analysis indicated that 200 mg/kg hydro 
alcoholic extract of A. africanus roots and aerial parts 
showed statistically significant difference on day 4 
parasitemia level, compared to the negative control. The 
400 mg/kg A. africanus roots and aerial parts also 
showed a statistically significant difference on the day 4 
parasitemia level. A high level (46.12 % inhibition with 
the 600 mg/kg), A. africanus roots and a 40.73% 
inhibition of A. africanus aerial parts was also observed. 
Therefore, the highest level of inhibition (46.12 %) was 
observed in 600 mg/kg of A. africanus roots (Table 1). 
 
Table 1:  Parasitemia suppressive test of hydro alcoholic extracts of A. africanus roots and aerial parts against P. 
berghei in mice, 2005 
Test substances Dose mg/kg % parasitemia % inhibition 
200 35.27±0.14 13.62 
400 29.46±0.48 27.84 
1.  A. africanus roots 
600 22.00±0.11 46.12 
Vehicle 1 ml (-) 40.830.29 0.00 
Chloroquine 10 (+) 0.00 100.00 
200 45.25±0.29 13.47 
400 40.45±0.21 22.67 
2.  A. africanus aerial parts 
600 31.00±0.24 40.73 
Vehicle 1 ml (-) 52.30±0.38 0.00 
Chloroquine 10 (+) 0.00 100.00 
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The test extracts of A. africanus roots and aerial parts 
prevented a loss of body weight in infected mice with 
increasing parasitemia. The comparison analysis 
indicated that the extracts significantly prevented weight 
loss at all dose levels compared to the controls.  
However, the increase in body weight was not found to 
be dependent on dose levels (Table 2).  
 
Table 2:  Body weight of P. berghei infected mice after the administration of A.africanus hydro alcoholic 
extracts, 2005. 
Test substances Dose mg/kg Wt. D-0 Wt. D-4 % change 
200 30.26±0.33 32.20±0.97 6.41 
400 27.30±0.38 28.50±0.26 4.40 
1.  A. africanus 
roots 
600 32.30±0.33 33.20±0.43 2.78 
Vehicle 1 ml 29.40±0.34 28.64±0.47 -2.59 
Chloroquine 10 29.24±0.55 29.84±0.48 1.50 
200 29.97±1.30 31.07±0.60 3.67 
400 29.78±0.42 30.55±0.66 2.59 
2.  A. africanus 
aerial parts 
600 32.58±0.48 32.90±0.54 0.98 
Vehicle 1 ml 34.38±0.61 33.20±0.43 -3.43 
Chloroquine 10 29.66±0.25 30.10±0.27 1.48 
Day 0 = day infection was initiated  P<0.05 
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Figure 1:  Rectal temperature test for A. africanus hydroalcoholic extract of root against P. bergei in mice, 2005 
 
The analysis of Packed Cell Volume (PCV) on day 4, and 
an examinations of the rectal temperature indicated that 
the hydro alcoholic extract of both roots and aerial parts 
of A. africanus failed to significantly prevent the 
reduction in PCV and body temperature, although, some 
what lesser percentages of reduction and significant 
preventive effects were observed, compared to the 
controls at only a few dose levels.  
 
The  hydroalcoholic  extracts  of  A. africanus  roots  and  
aerial parts showed no lethality in up to 5,000 mg/kg of 
doses, when administered through intragastric routes 
(which is 25 minimum effective dose, 200 mg/kg). 
Similarly, intraperitoneal administration of the same 
extracts in doses of up to 1000 mg/kg did not produce 
lethality. The mice were monitored for over a week but 
no sign of toxicity was observed. Gross behavioural and 
physical observations revealed no lacrimation, no 
urination, no muscle weakness, no sedation and no 
convulsion. They were physically active.  
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Table 3:  packed cell volume tests of hydro alcoholic extracts of A. africanus roots and aerial parts against P. 
berghei in mice, 2005. 
Test substances Dose mg/kg D-0 PCV D-4 PCV % reduction 
200 52.61±0.32 43.24±0.42 17.81 
400 51.24±0.30 43.86±0.22 14.40 
1.  A. africanus 
roots 
600 53.42±0.31 43.73±0.41 18.40 
Vehicle 1 ml 52.02±0.25 42.34±0.37 18.61 
Chloroquine 10 51.38±0.34 48.27±0.45 6.05 
200 52.83±0.03 43.37±0.31 17.91 
400 51.80±0.44 43.6600.14 15.71 
2.  A. africanus 
aerial parts 
600 53.32±0.34 43.08±0.70 19.20 
Vehicle 1 ml 53.26±0.33 42.97±0.63 19.32 
Chloroquine 10 52.68±0.55 48.05±0.24 8.79 
P<0.05 
Day 0 = day infection initiated  Each result is a mean of 6 mice 








Although primate models provide a better prediction of 
efficacy in human than the rodent models, the latter have 
also been validated through the identification of several 
conventional antimalarials, such as chloroquine, 
halofantrine, mefloquine and more recently artemisinin 
derivatives (6). P. berghei are used in the prediction of 
treatment outcomes. Hence, it was an appropriate parasite 
for the study. As this parasite is sensitive to chloroquine, 
this drug was employed as a standard drug in this study. 
 
The 4-day suppressive test is a standard test commonly 
used for antimalarial screening, and the determination of 
percent inhibition of parasitemia is the most reliable 
parameter. A mean group parasitemia level of less than 
or equal to 90% that of mock-treated control animals 
usually indicates that the test compound is active in 
standard screening studies (2). Therefore, it is clear from 
the result (table 1) that in P. berghei infected mice treated 
with the extracts of A. africanus roots and aerial parts, the 
percentage of parasitemia measured changed significantly 
from those in the control animals. This significant 
suppression of parasitemia by the hydroalcoholic extract of 
A. africanus on day 4 was also in agreement with that 
shown for a water extract employed against four different 
malaria schizont strains in vitro (26). The observed 
antimalarial activity is consistent with the traditional use of 
the plant as a herbal medication against the disease in south 
Ethiopia (21).  
 
When a standard antimalarial drug is used in mice 
infected with P. berghei, it suppresses parasitemia to 
non-detectable levels (23), which is in agreement with 
the effects of chloroquine in this study. The observed 
protection of the infected animals from loosing body 
weight by the roots extract in the present study is in 
conformity with previous studies (30). The much higher 
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chloroquine might be attributed to the presence of several 
nutrients and immunomodulatory substances, in addition 
to the anti-parasitic activity (31).  
 
However, although the results clearly indicated that the 
test extracts of A. africanus roots and aerial parts 
significantly prevented weight loss at all dose levels 
compared to the controls, the increase in body weight is 
not consistent with increasing dose of the extracts. The 
percentage change (% preventive effect) declines with 
increasing dose, which is consistent with both plant parts. 
It may possibly indicate the appetite suppressive effects 
of the extracts, which would reasonably increase with 
increasing dose. This in turn can affect the feeding 
capability of the mice and could cause a relative 
reduction in body weight, which could be indicative of 
toxicity. However, the toxicity tests of the present study 
do not indicate any other toxicity manifestation at 
reasonably higher doses and no death was observed 
before five days. 
 
In untreated mice, the parasite count increased and the 
hematocrit packed cell volume (PCV) decreased 
markedly from day to day until the death of the animal, 
which was also observed in previous studies (15). 
Although lesser percentage reduction in PCV and rectal 
temperature were observed in the present study with the 
plant extracts and significant preventive effects were 
observed at some dose levels, the overall effects were not 
consistent and conclusive, both in the case of PCV and 
the rectal temperature.  
 
In general, if the lethal dose (LD50) of the test substance 
is three times more than the minimum effective dose 
(MED), the substance is considered a good candidate for 
further studies. It was also suggested that oral 
administration is about 100 times less toxic than 
intraperitoneal (30). However, the hydro alcoholic 
extracts showed no lethality to mice at 5,000 mg/kg, 
which is 25 times the MED and no gross behavioural and 
physical changes were revealed. Intraperitoneal 
administration also did not produce lethality at doses of 
up to 1000 mg/kg. It was difficult to give higher doses 
because of the viscosity of the extracts (being unable to 
pass through intraperitoneal needle). Therefore, 
observations that no death with upto an oral dose of 5000 
mg/kg and an intraperitoneal dose of 1000 mg/kg could 
indicate that the test extracts are very safe. This could 
also explain the safe use of the plant by the local people, 
who have been using it in traditional treatment of 
malaria, in Southern Ethiopia.  
 
From the present study, it can be concluded that the 
hydroalcoholic extracts of the root and aerial parts of 
Asparagus africanus have shown parasite suppressive 
effects on P.berghei infected Swiss albino mice in a dose-
related fashion, whereas the effects on Packed Cell 
Volume and body temperature are inconclusive. 
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